Eculizumab: A Review in Generalized Myasthenia Gravis
Sign Up to like & getrecommendations! Published in 2018 at "Drugs"
DOI: 10.1007/s40265-018-0875-9
Abstract: The humanized monoclonal antibody eculizumab (Soliris®) is a complement inhibitor indicated for use in anti-acetylcholine receptor (AChR) antibody-positive adults with generalized myasthenia gravis (gMG) in the USA, refractory gMG in the EU, or gMG with… read more here.
Keywords: eculizumab review; generalized myasthenia; eculizumab; myasthenia gravis ... See more keywords